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We have previously shown that a higher burden of
CD14+HLA-DRlo/neg cells in the peripheral blood of
cancer patients is associated with systemic immune sup-
pression and a poor outcome. We have also reported
that CD14+ cells isolated from healthy donors are con-
verted to the immunosuppressive CD14+HLA-DRlo/neg
phenotype when cocultured with tumor cell lines or pri-
mary tumor cultures. Therefore, one potential mechan-
ism of CD14+HLA-DRlo/neg generation in cancer
patients is the recruitment of CD14+ cells to the tumor
microenvironment. In this study, we tested the ability of
multiple human lung cancer cell lines to recruit CD14+
cells, convert normal donor CD14+ cells to CD14
+HLA-DRlo/neg, and the impact on tumor survival under
stress conditions in the presence of CD14+HLA-DRlo/neg
cells. Monocyte recruitment by cell line supernatants
was studied using freshly isolated CD14+ cells and mea-
sured in real time with live cell imaging. Monocytes
from 10/10 unique healthy donors migrated towards
H23 supernatant in a dose dependent fashion. Superna-
tants from other human lung cancer cell lines including
H889, H1155, H1581, and H1975 also recruited healthy
donor monocytes 6 to 9 fold greater than culture media
alone. The CD14+ phenotype resulting from interaction
with lung cancer cell lines was studied in a 2 day cocul-
ture system. Coculture of H1581 with monocytes from
27 of 29 unique healthy donors resulted in a downregu-
lation of monocyte cell surface expression of HLA-DR
by 48.7% ± 22.1%, a phenotype known to mediate both
local and systemic immune suppression. C14+ HLA-DR
downregulation after coculture was observed with H23 (17/
18 unique healthy donors, 49.7% ± 22.1% HLA-DR reduc-
tion) and H889 (5/6 unique healthy donors, 47.3% ± 16.1%
HLA-DR reduction). Importantly, CD14+ cells promoted
lung tumor cell line survival under stress conditions. After
6 days of low serum growth conditions, the survival and
proliferation of H23 and H1581 was approximately 2 fold
greater when cocultured with CD14+ cells than without
monocytes. H889 continuously exposed to cisplatin in cul-
ture had significantly improved survival when co-cultured
with monocytes for 2 days prior to cisplatin exposure. In
conclusion, we have demonstrated multiple lung cancer
cell lines recruit and transformation monocytes to the
HLA-DRlo/neg phenotype. These data suggest monocyte
cancer cross-talk results in improved tumor survival when
exposed to the likely in vivo conditions of a nutrient poor
environment or chemotherapy independent of local
immune suppression and angiogenesis.
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